Publikationen von Florian Holsboer

Eisensamer, B.; Uhr, M.; Meyr, S.; Gimpl, G.; Deiml, T.; Rammes, G.; Lambert, J. J.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antidepressants and antipsychotic drugs colocalize with 5-HT₃ receptors in raft-like domains. The Journal of Neuroscience 25 (44), S. 10198 - 10206 (2005)

Modell, S.; Ising, M.; Holsboer, F.; Lauer, C. J.: The Munich vulnerability study on affective disorders: Premorbid polysomnographic profile of affected high-risk probands. Biological Psychiatry 58 (9), S. 694 - 699 (2005)

Barden, N.; Harvey, M.; Gagne, B.; Raymond, C.; Labbe, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.: A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 82 - 82 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 44 - 44 (2005)

Horstmann, S.; Ising, M.; Lucae, S.; Kloiber, S.; Dose, T.; Salyakina, D.; Pütz, B.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.: The cortisol and ACTH response in the combined Dex/CRH test of acutely depressed patients varies significantly between 5-HT2A receptor genotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 48 - 48 (2005)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 45 - 45 (2005)

Prokopenko, I.; Tozzi, F.; Perry, J. D.; McCarthy, A. D.; Chissoe, S. L.; St Jean, P. L.; Alalouff, S.; Brewster, S. R.; Kennedy, J. L.; Middleton, L. T. et al.; Holsboer, F.; Muglia, P.: Major depressive disorder: Identifying phenotypic subtypes for genetic studies. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 107 - 107 (2005)

Baghai, T. C.; Binder, E. B.; Holsboer, F.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism. Pharmacopsychiatry 38 (5), S. 228 - 228 (2005)

Deussing, J. M.; Kühne, C.; Panhuysen, M.; Pütz, B.; Breu, J.; Paez-Pereda, M.; Holsboer, F.; Wurst, W.: Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways. Pharmacopsychiatry 38 (5), S. 236 - 236 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Kern, N.; Unschuld, P. G.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry 38 (5), S. 240 - 240 (2005)

Friess, E.; Ambrosius, U.; Lietzenmayer, S.; Wichniak, A.; Winkelmann, J.; Yassouridis, A.; Holsboer, F.: Sleep architecture and sleep continuity in healthy twins. Pharmacopsychiatry 38 (5), S. 241 - 242 (2005)

Himmerich, H.; Binder, E. B.; Künzel, H.; Schuld, A.; Lucae, S.; Uhr, M.; Pollmächer, T.; Holsboer, F.; Ising, M.: Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Pharmacopsychiatry 38 (5), S. 249 - 249 (2005)

Ising, M.; Binder, E. B.; Dose, T.; Horstmann, S.; Kern, N.; Kloiber, S.; Künzel, H. E.; Lucae, S.; Pfennig, A.; Unschuld, P. G. et al.; Modell, S.; Holsboer, F.: Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 38 (5), S. 251 - 251 (2005)

Kirmeier, T.; Turck, C. W.; Holsboer, F.; Rein, T.: Proteomic search for intracellular binding sites of antidepressants. Pharmacopsychiatry 38 (5), S. 254 - 254 (2005)

Kloiber, S.; Ising, M.; Lucae, S.; Lieb, R.; Holsboer, F.: Implications of obesity and medical illness for major depression - a different endophenotype of major depression in obese patients? Pharmacopsychiatry 38 (5), S. 254 - 254 (2005)

Lang-Rollin, I. C.; Wochnik, G. M.; Holsboer, F.; Rein, T.: Effects of TPR proteins on steroid receptor signaling. Pharmacopsychiatry 38 (5), S. 259 - 259 (2005)

Lu, A.; Steiner, M.; Engelholm, M.; Engelholm, M.; Wotjak, C. T.; Holsboer, F.; Wurst, W.; Deussing, J. M.: Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry 38 (5), S. 261 - 261 (2005)

Müller, M. B.; Sterlemann, V.; Ganea, K.; Alam, S.; Holsboer, F.; Schmidt, M.: Towards a new animal model for stress related disorders. Behavioural Pharmacology 16 (Suppl. 1), S. S71 - S71 (2005)

Reppermund, S.; Horstmann, S.; Lucae, S.; Kloiber, S.; Dose, T.; Holsboer, F.; Ising, M.: Stress coping and personality traits in acute depression and after improvement. Pharmacopsychiatry 38 (5), S. 271 - 271 (2005)

Sterlemann, V.; Schmidt, M.; Alam, S.; Ganea, K.; Greetfeld, M.; Holsboer, F.; Müller, M. B.: A new model of chronic social stress in mice: long-term neuroendocrine and behavioural consequences. Pharmacopsychiatry 38 (5), S. 279 - 279 (2005)